Clinical Trial Update: Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Taxotere-based combinations as first-line therapy for locally advanced unresectable or metastatic non-small cell lung cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED